Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

Completed · Not applicable

Conditions studied: Facial Wrinkles

In brief

The aim of this prospective, randomized, double-blind, intraindividual split face study will be to compare onabotulinumtoxinA to incobotulinumtoxinA for the correction of facial wrinkles using a 1:1 dose ratio.

Key facts

Study ID

NCT02122536

Run by

YMD Eye and Face

People needed

45

Starts

2012-07-01

Expected to finish

2013-11-01

Last updated by the study team

2014-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• males and females age 18 or older.

You may not qualify if…

• Previous treatment with a neuromodulator in the last 6 months
• previous brow lift
• currently pregnant or breastfeeding
• a history of neurological disease or deficit
• an active facial skin infection
• an allergy to neuromodulators

Where it is running

• Center for Sight — Sarasota, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.